This announcement is a separate document:
中准会计师事务所（特殊普通合伙）关于黑龙江珍宝岛药业股份有限公司《2023年年度报告的信息披露监管工作函》相关问题的回复
Reply to the Information Disclosure Supervision Letter on the Annual Report 2023 of Heilongjiang ZBD Pharmaceutical Co., Ltd. by Zhongzhun Certified Public Accountants (Special General Partnership).
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.